Patrick H. Nachman

8.9k total citations
91 papers, 4.9k citations indexed

About

Patrick H. Nachman is a scholar working on Nephrology, Pulmonary and Respiratory Medicine and Genetics. According to data from OpenAlex, Patrick H. Nachman has authored 91 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Nephrology, 48 papers in Pulmonary and Respiratory Medicine and 24 papers in Genetics. Recurrent topics in Patrick H. Nachman's work include Renal Diseases and Glomerulopathies (52 papers), Vasculitis and related conditions (44 papers) and Chronic Kidney Disease and Diabetes (16 papers). Patrick H. Nachman is often cited by papers focused on Renal Diseases and Glomerulopathies (52 papers), Vasculitis and related conditions (44 papers) and Chronic Kidney Disease and Diabetes (16 papers). Patrick H. Nachman collaborates with scholars based in United States, Canada and France. Patrick H. Nachman's co-authors include J. Charles Jennette, Ronald J. Falk, Susan L. Hogan, Caroline E. Jennette, Yichun Hu, Hyunsook Chin, Sophia Lionaki, Vimal K. Derebail, Caroline J. Poulton and Alice S. Wilkman and has published in prestigious journals such as Journal of Clinical Investigation, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Patrick H. Nachman

84 papers receiving 4.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Patrick H. Nachman United States 39 3.2k 2.2k 1.4k 1.3k 866 91 4.9k
Pieter van Paassen Netherlands 37 3.1k 1.0× 1.2k 0.5× 1.1k 0.8× 1.5k 1.2× 1.2k 1.4× 113 4.8k
Rachel Jones United Kingdom 27 3.4k 1.1× 935 0.4× 1.4k 1.0× 1.9k 1.5× 986 1.1× 71 4.7k
Kerstin Westman Sweden 33 7.0k 2.2× 1.8k 0.8× 2.6k 1.9× 3.2k 2.6× 1.1k 1.3× 71 7.8k
Matthew D. Morgan United Kingdom 21 2.0k 0.6× 594 0.3× 761 0.6× 952 0.8× 522 0.6× 41 2.8k
Hasan Yazıcı Türkiye 19 2.1k 0.7× 422 0.2× 578 0.4× 1.8k 1.4× 451 0.5× 57 3.4k
Joanna Robson United Kingdom 27 2.3k 0.7× 346 0.2× 634 0.5× 1.5k 1.2× 369 0.4× 92 2.8k
Véronique Le Guern France 29 996 0.3× 597 0.3× 215 0.2× 1.9k 1.6× 622 0.7× 111 3.4k
David Carruthers United Kingdom 23 1.7k 0.5× 287 0.1× 487 0.4× 1.3k 1.0× 429 0.5× 40 2.6k
Sophia Lionaki Greece 20 982 0.3× 727 0.3× 432 0.3× 642 0.5× 454 0.5× 74 1.9k
Víctor M. Martínez‐Taboada Spain 19 1.4k 0.4× 307 0.1× 520 0.4× 1.3k 1.0× 402 0.5× 65 2.5k

Countries citing papers authored by Patrick H. Nachman

Since Specialization
Citations

This map shows the geographic impact of Patrick H. Nachman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick H. Nachman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick H. Nachman more than expected).

Fields of papers citing papers by Patrick H. Nachman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick H. Nachman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick H. Nachman. The network helps show where Patrick H. Nachman may publish in the future.

Co-authorship network of co-authors of Patrick H. Nachman

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick H. Nachman. A scholar is included among the top collaborators of Patrick H. Nachman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick H. Nachman. Patrick H. Nachman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Boyer‐Suavet, Sonia, Marine Andreani, Vesna Brglez, et al.. (2020). Neutralizing Anti-Rituximab Antibodies and Relapse in Membranous Nephropathy Treated With Rituximab. Frontiers in Immunology. 10. 3069–3069. 74 indexed citations
2.
Mendoza, Carmen, Anne Froment, Yichun Hu, et al.. (2019). Elevated Microparticle Tissue Factor Activity Differentiates Patients With Venous Thromboembolism in Anti-neutrophil Cytoplasmic Autoantibody Vasculitis. Kidney International Reports. 4(11). 1617–1629. 16 indexed citations
3.
Alba, Marco A., Luis Felipe Flores-Suárez, Ashley G. Henderson, et al.. (2017). Interstital lung disease in ANCA vasculitis. Autoimmunity Reviews. 16(7). 722–729. 100 indexed citations
4.
Gasim, Adil, Caroline J. Poulton, Susan L. Hogan, et al.. (2016). Treatment with Glucocorticoids or Calcineurin Inhibitors in Primary FSGS. Clinical Journal of the American Society of Nephrology. 11(3). 386–394. 36 indexed citations
5.
Lee, Taewoo, Vimal K. Derebail, Abhijit V. Kshirsagar, et al.. (2016). Patients with primary membranous nephropathy are at high risk of cardiovascular events. Kidney International. 89(5). 1111–1118. 56 indexed citations
6.
Thompson, Aliza, Daniel Cattran, Melanie Blank, & Patrick H. Nachman. (2015). Complete and Partial Remission as Surrogate End Points in Membranous Nephropathy. Journal of the American Society of Nephrology. 26(12). 2930–2937. 69 indexed citations
7.
Hogan, Susan L., Caroline J. Poulton, Yichun Hu, et al.. (2015). Rituximab as an immunosuppressant in antineutrophil cytoplasmic antibody-associated vasculitis. Nephrology Dialysis Transplantation. 30(suppl_1). i123–i131. 20 indexed citations
8.
Roth, Aleeza J., Joshua D. Ooi, Mirjan M. van Timmeren, et al.. (2013). Epitope specificity determines pathogenicity and detectability in ANCA-associated vasculitis. Journal of Clinical Investigation. 123(4). 1773–1783. 184 indexed citations
9.
Lee, Taewoo, Andrea K. Biddle, Sophia Lionaki, et al.. (2013). Personalized prophylactic anticoagulation decision analysis in patients with membranous nephropathy. Kidney International. 85(6). 1412–1420. 69 indexed citations
10.
Hicks, Andrew A., Carl D. Langefeld, Lingyi Lu, et al.. (2011). Sickle cell trait is not independently associated with susceptibility to end-stage renal disease in African Americans. Kidney International. 80(12). 1339–1343. 25 indexed citations
11.
Mcgregor, J., Susan L. Hogan, Yichun Hu, et al.. (2011). Glucocorticoids and Relapse and Infection Rates in Anti-Neutrophil Cytoplasmic Antibody Disease. Clinical Journal of the American Society of Nephrology. 7(2). 240–247. 95 indexed citations
12.
Derebail, Vimal K., Patrick H. Nachman, Nigel S. Key, et al.. (2011). Variant hemoglobin phenotypes may account for differential erythropoiesis-stimulating agent dosing in African-American hemodialysis patients. Kidney International. 80(9). 992–999. 11 indexed citations
13.
Barbour, Sean J., Allen Greenwald, Ognjenka Djurdjev, et al.. (2011). Disease-specific risk of venous thromboembolic events is increased in idiopathic glomerulonephritis. Kidney International. 81(2). 190–195. 135 indexed citations
14.
Geetha, Duvuru, Alfonso Eirin, Karin True, et al.. (2011). Renal Transplantation in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Multicenter Experience. Transplantation. 91(12). 1370–1375. 58 indexed citations
15.
Fervenza, Fernando C., Roshini S. Abraham, Stephen B. Erickson, et al.. (2010). Rituximab Therapy in Idiopathic Membranous Nephropathy. Clinical Journal of the American Society of Nephrology. 5(12). 2188–2198. 207 indexed citations
16.
Lionaki, Sophia, Susan L. Hogan, Caroline E. Jennette, et al.. (2009). The clinical course of ANCA small-vessel vasculitis on chronic dialysis. Kidney International. 76(6). 644–651. 101 indexed citations
17.
Joy, Melanie S., Susan L. Hogan, J. Charles Jennette, Ronald J. Falk, & Patrick H. Nachman. (2005). A pilot study using mycophenolate mofetil in relapsing or resistant ANCA small vessel vasculitis. Nephrology Dialysis Transplantation. 20(12). 2725–2732. 85 indexed citations
18.
Hogan, Susan L., et al.. (2001). Silica Exposure in Anti-Neutrophil Cytoplasmic Autoantibody-Associated Glomerulonephritis and Lupus Nephritis. Journal of the American Society of Nephrology. 12(1). 134–142. 126 indexed citations
19.
Dooley, Mary Anne, Fernando G. Cosio, Patrick H. Nachman, et al.. (1999). Mycophenolate Mofetil Therapy in Lupus Nephritis. Journal of the American Society of Nephrology. 10(4). 833–839. 179 indexed citations
20.
Nachman, Patrick H., Mårten Segelmark, Kerstin Westman, et al.. (1999). Recurrent ANCA-associated small vessel vasculitis after transplantation: A pooled analysis. Kidney International. 56(4). 1544–1550. 115 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pieter van Paassen Breakdown of academic impact, for papers by Rachel Jones Breakdown of academic impact, for papers by Kerstin Westman Breakdown of academic impact, for papers by Matthew D. Morgan Breakdown of academic impact, for papers by Hasan Yazıcı Breakdown of academic impact, for papers by Joanna Robson Breakdown of academic impact, for papers by Véronique Le Guern Breakdown of academic impact, for papers by David Carruthers Breakdown of academic impact, for papers by Sophia Lionaki Breakdown of academic impact, for papers by Víctor M. Martínez‐Taboada
Rankless by CCL
2026